Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities

@article{Rodrigues2020HistoneDA,
  title={Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities},
  author={D. A. Rodrigues and P. S. M. Pinheiro and F. S. Sagrillo and M. Bolognesi and C. A. M. Fraga},
  journal={Medicinal Research Reviews},
  year={2020},
  volume={40},
  pages={2177 - 2211}
}
Despite the applicability of histone deacetylase inhibitors (HDACis) for cancer treatment, several works in the literature have shown that these inhibitors can be used in several other diseases, such as neurodegenerative diseases (NDs). This review begins by discussing the signaling pathways of HDACs, focused on the context of NDs, presenting a discussion about the pharmacophoric features of HDACis and crystal structure analysis and discussing interesting case studies from the literature about… Expand

References

SHOWING 1-10 OF 188 REFERENCES
HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
Anticancer activities of histone deacetylase inhibitors
Histone Deacetylase Inhibitors: Overview and Perspectives
Towards isozyme-selective HDAC inhibitors for interrogating disease.
The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease
Beyond the Selective Inhibition of Histone Deacetylase 6.
Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases.
...
1
2
3
4
5
...